Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

515 recalls, newest first

Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.

Completed Sterility / contamination B. Braun Medical Inc. NDC 0264-5802-10 D-0347-2023
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.

Completed Sterility / contamination B. Braun Medical Inc. NDC 0264-5802-00 D-0346-2023
Class II · Moderate risk

Fentanyl 500mcg

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

Ongoing Sterility / contamination Apollo Care NDC 71170-950-25 D-0487-2023
Class I · High risk

Artificial Tears

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Ongoing Sterility / contamination Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0919-2023

Recalls by year